Serial Number
88734627
Owner
CORVAL LLCAttorney
Emily C. TsengFirst Use Date
Jun 24, 2022
Filing Date
Dec 20, 2019
CORVAL Trademark
Serial Number: 88734627 • Registration: 6866762
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
December 20, 2019
Registration Date
October 4, 2022
First Use Anywhere
June 24, 2022
First Use in Commerce
June 24, 2022
Published for Opposition
November 9, 2021
Goods & Services
Consulting services in the fields of life sciences and biotechnology, namely, providing business planning and strategy services to manufacturers relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Consulting services in the fields of life sciences and biotechnology, namely, providing strategic roadmaps to manufacturers to inform business planning, identify objectives and track activities relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease
Providing software as a service (SaaS), namely, non-downloadable web-based software for use by manufacturers in the fields of life sciences and pharmaceuticals for facilitating and streamlining the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Providing collaborative planning and technology solutions to manufacturers in the fields of life sciences and pharmaceuticals, namely, providing web-based software for cloud-based collaboration and strategic planning relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease; Development and implementation of collaborative planning and technology solutions for use by manufacturers in the fields of life sciences and pharmaceuticals, namely, development and implementation of web-based software that enables users to connect and collaborate with each other to plan business and market entry strategies relating to the commercialization of new pharmaceutical drugs, biopharmaceuticals, and therapeutics for the treatment of disease
